Expertise in
17
conditions

Masatoshi Jinnin

Wakayama, JP 
Expertise in
17
conditions
Wakayama, JP 

Overview

Masatoshi Jinnin practices practicing medicine in Wakayama, Japan.

Mr. Jinnin is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Vascular Birthmark, and Hemangioma.

He is actively involved in clinical research, co-authoring 231 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Wakayama, Japan
Other Locations
Kimiidera, 6410012, Japan
Gifu-shi, Japan
Kumamoto, Japan
Chuo, Japan
Honjo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

231 Total Publications

Exploratory study on the effect of ferulic acid derived from rice bran on dull skin.
Exploratory study on the effect of ferulic acid derived from rice bran on dull skin.
Journal: Drug discoveries & therapeutics
Published: June 21, 2026

Frequently Asked Questions about Masatoshi Jinnin

Is Masatoshi Jinnin a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Masatoshi Jinnin is classified as an Distinguished expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masatoshi Jinnin participate in research or clinical trials?

Yes. Masatoshi Jinnin has published 231 articles and abstracts on conditions like Scleroderma. You can view a list of Masatoshi Jinnin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jinnin's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 9 Advanced Conditions
    View All 51 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile